MGH, Alnylam, MIT Researchers Report on siRNA Inhibition of Inflammation | GenomeWeb

Massachusetts General Hospital last week published data showing that siRNAs could be used to block inflammation in mice by silencing CCR2 in monocytes.

Investigators from Alnylam Pharmaceuticals and the Massachusetts Institute of Technology contributed to the report, which appeared in Nature Biotechnology.

“Inflammatory monocytes, but not the non-inflammatory subset, depend on the chemokine receptor CCR2 for localization to injured tissue,” the researchers wrote.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.